Tuesday, February 07, 2017 2:16:31 AM
Recent action on shares of Xplore Technologies Corp. (NASDAQ:XPLR) lands the stock on today’s most volatile list. In the current trading session, the stock has seen a change of -10.51% recently hitting $1.96.
Share prices are capable of moving sharply higher or lower in a very short amount of time. Keeping an eye on the volatile stocks may help spot market abnormalities.Based on data provided from analysts polled by Thomson Reuters, Xplore Technologies Corp. has a current consensus target price of 4.20. The current consensus analyst recommendation is sitting at 2.50 on company shares. Investors will likely be tracking any consensus estimate changes heading into the next earnings period.
After a recent spot-check, Xplore Technologies Corp. (NASDAQ:XPLR)’s ATR is 0.17. The Average True Range (ATR) is a measure of stock volatility. The Average True Range is an exponential moving average (14-days) of the True Range. The range of a day’s trading is high-low, and True Range expands into yesterday’s close when it lands outside of today’s range.
Taking a closer look into the volatility on shares of Xplore Technologies Corp. (NASDAQ:XPLR), we notice that the stock is -16.38% off of the 20-Day Simple Moving Average. Zooming out to the 50-Day Simple Moving Average, we can see a difference of -13.15% from current stock levels.
Going out even further, the 200-Day Simple Moving Average is recorded -21.82% away from the current share price. Company shares were recently noted -24.62% off of the 50-day high and -2.00% away from the 50-day low. Let’s also take a quick peek at the 52 week highs/lows. At present, the stock is -55.91% separated from the 52 week high and 7.69% from the low.
https://davidsonregister.com/volatility-spiking-as-shares-ride-the-wave-xplore-technologies-corp-nasdaqxplr/23426/
Recent XPLR News
- TSX Venture Exchange Stock Maintenance Bulletins • PR Newswire (Canada) • 10/21/2023 01:34:00 AM
- TSX Venture Exchange Stock Maintenance Bulletins • PR Newswire (Canada) • 10/20/2023 12:03:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM